News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
408,062 Results
Type
Article (26670)
Company Profile (70)
Press Release (381322)
Section
Business (114865)
Career Advice (453)
Deals (19330)
Drug Delivery (47)
Drug Development (50675)
Employer Resources (47)
FDA (12855)
Job Trends (8714)
News (203403)
Policy (21080)
Tag
Academia (1765)
Alliances (30695)
Alzheimer's disease (773)
Approvals (12859)
Artificial intelligence (105)
Bankruptcy (143)
Best Places to Work (7021)
Breast cancer (140)
Cancer (967)
Cardiovascular disease (81)
Career advice (413)
Cell therapy (156)
Clinical research (42328)
Collaboration (311)
Compensation (74)
COVID-19 (1529)
C-suite (75)
Data (1015)
Diabetes (116)
Diagnostics (3606)
Earnings (40012)
Events (54238)
Executive appointments (285)
FDA (13449)
Funding (270)
Gene therapy (92)
GLP-1 (349)
Government (3070)
Healthcare (12497)
Infectious disease (1581)
Inflammatory bowel disease (73)
IPO (7805)
Job creations (1976)
Job search strategy (383)
Layoffs (160)
Legal (4220)
Lung cancer (160)
Lymphoma (65)
Manufacturing (87)
Medical device (12853)
Medtech (12857)
Mergers & acquisitions (11695)
Metabolic disorders (309)
Neuroscience (986)
NextGen: Class of 2025 (4014)
Non-profit (2831)
Northern California (964)
Obesity (175)
Opinion (64)
Parkinson's disease (64)
Patents (70)
People (36367)
Phase I (12113)
Phase II (18314)
Phase III (15036)
Pipeline (326)
Postmarket research (1760)
Preclinical (3886)
Radiopharmaceuticals (161)
Rare diseases (135)
Real estate (3221)
Regulatory (14876)
Research institute (1631)
Southern California (846)
Startups (2312)
United States (9208)
Vaccines (308)
Weight loss (119)
Date
Today (10)
Last 7 days (472)
Last 30 days (1089)
Last 365 days (20688)
2025 (515)
2024 (21022)
2023 (24077)
2022 (32787)
2021 (35123)
2020 (34393)
2019 (29944)
2018 (23047)
2017 (20515)
2016 (19611)
2015 (23129)
2014 (17581)
2013 (14711)
2012 (15834)
2011 (16252)
2010 (14817)
Location
Africa (393)
Arizona (97)
Asia (34314)
Australia (5004)
California (2148)
Canada (976)
China (267)
Colorado (117)
Connecticut (124)
Delaware (69)
Europe (53837)
Florida (363)
Georgia (88)
Illinois (275)
Indiana (165)
Japan (79)
Kansas (68)
Maryland (486)
Massachusetts (1548)
Michigan (81)
Minnesota (212)
New Jersey (779)
New York (660)
North Carolina (452)
Northern California (964)
Ohio (95)
Pennsylvania (599)
South America (572)
Southern California (846)
Texas (351)
Utah (74)
Washington State (169)
408,062 Results for "saluda medical pty ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Saluda Medical Announces Closing of $100 Million Financing
January 10, 2025
·
2 min read
Business
Saluda Medical Appoints Jim Erickson as Chief Financial Officer
Saluda Medical, Inc. announced the appointment of Jim Erickson as Chief Financial Officer.
December 14, 2023
·
3 min read
BioMidwest
Saluda Medical Announces Late Breaking Data at NANS 2024 Annual Meeting
Saluda Medical, Inc. today announced the company’s data will be presented at the North American Neuromodulation Society (NANS) 2024 Annual Meeting, taking place January 18-21.
January 16, 2024
·
3 min read
FDA
Saluda Medical Receives FDA Approval for Evoke® System MRI Labeling
Saluda Medical, Inc. (“Saluda Medical”) today announced that the U.S. Food and Drug Administration (FDA) has approved MRI conditional labeling for the Evoke® System, the first and only precision, dose-control spinal cord stimulation (SCS) therapy powered by SmartLoop™ technology.
September 26, 2023
·
2 min read
Press Releases
Saluda Medical Announces Presentation of Two Chronic Pain Biomarker-Based Analyses at ASPN 2024 Annual Conference
July 18, 2024
·
4 min read
Press Releases
Halia Therapeutics Joins Forces with Southern Star Research Pty Ltd to Advance Clinical Development of Novel LRRK2 Inhibitor, HT-4253 for Neurodegenerative Diseases
September 3, 2024
·
4 min read
Saluda Medical Announces Presentation of 36-Month Trial Data at NANS 2023 Annual Meeting
Saluda Medical Pty Limited (“Saluda Medical”), a global medical device company revolutionizing the field of neuromodulation, today announced that late-breaking data from the landmark EVOKE Clinical Trial was presented at the 2023 North American Neuromodulation Society (NANS) Annual Meeting.
January 17, 2023
·
4 min read
Business
Saluda Medical Appoints Laureen DeBuono to Board of Directors
Saluda Medical Pty Limited, a global medical device company revolutionizing the field of neuromodulation with an emerging portfolio of therapies driven by advanced neural activation and sensing technologies, announced the appointment of Laureen DeBuono to its board of directors.
October 4, 2022
·
3 min read
BioMidwest
Saluda Medical Announces Publication of Favorable Economic Analysis Demonstrating Cost-Dominance of Evoke® Closed-Loop SCS over Open-Loop SCS
Saluda Medical, Inc. announced the publication of new health economic data in The Clinical Journal of Pain that provides the strongest ever economic case for the use of Evoke® Closed-Loop SCS with physiologic SmartLoop™ technology over open-loop SCS therapy.
August 4, 2023
·
3 min read
Press Releases
WORK Medical Technology Group LTD’s Subsidiary, Hangzhou Shanyou, Showcases Products at MEDICA Trade Fair 2024
November 28, 2024
·
4 min read
1 of 40,807
Next
